Status:

ENROLLING_BY_INVITATION

Evaluating Cognitive Changes on Patients in Chemotherapy (ECCPC)

Lead Sponsor:

Ellis Medicine

Conditions:

Chemotherapy-related Cognitive Impairment

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

This randomized clinical trial aims to evaluate the impact of a structured low-intensity exercise program on cognitive function in adult cancer patients undergoing chemotherapy. The study enrolls 100 ...

Detailed Description

Chemotherapy-related cognitive impairment (CRCI) is a well-documented side effect of cancer treatment, yet its underlying mechanisms remain poorly understood and effective interventions are lacking. E...

Eligibility Criteria

Inclusion

  • • Age 18 years and older.
  • Patients with histologically confirmed malignancy who are planning on receiving chemotherapy.
  • Able and willing to provide written informed consent.
  • ECOG performance status less than or equal to 2.
  • Patients willing and able to perform the exercise as directed.
  • Patients with the ability to walk without use of an assistive device.
  • Patients with no underlying psychiatric disorder (other than depression, as long as there has been no acute presentation within 6 months of being enrolled in the study).

Exclusion

  • • Under the age of 18 years.
  • Patients unable to provide informed consent.
  • Patients who are non-ambulatory or who have a physical disability preventing exercise.
  • ECOG performance status greater than 2.
  • Patients with a psychiatric diagnosis (other than depression)
  • Patients with a diagnosis of dementia of any type.
  • Patients with a neurologic disorder that one could reasonably assume to have an underlying cognitive impairment.
  • Patients with a history of traumatic brain injury.
  • Patients who will be on chemotherapy for longer than 6 months

Key Trial Info

Start Date :

June 9 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 20 2027

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT06950190

Start Date

June 9 2025

End Date

February 20 2027

Last Update

August 12 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ellis Medicine/Roswell Park Medical Oncology

Schenectady, New York, United States, 12308